What It Is

5-Amino-1MQ is a small molecule researched for its potential effects on metabolism, fat storage, and cellular energy regulation. Its primary target is nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolism.

By inhibiting NNMT, 5-Amino-1MQ may influence the availability of molecules involved in cellular energy production and metabolic signaling — researchers are particularly interested in whether this pathway can influence fat metabolism, energy utilization, and adipose tissue regulation.

Who May Benefit

• Body-fat reduction and body-composition research
• Metabolic-health research
• Fat metabolism and energy-utilization research
• Complementing appetite-regulating compounds with a different mechanism

What to Expect

5-Amino-1MQ is generally approached as a consistent, longer-term metabolic strategy rather than a compound expected to produce an immediate noticeable effect.

Current human evidence is not sufficient to predict exactly how much body fat or weight an individual may lose — it should be viewed as a metabolic research compound, not a substitute for nutrition, training, sleep, or calorie management.

What to Pair It With

Reconstitution

Suggested Research Dosing Strategy

Administration Notes

Morning, subcutaneous administration in an area such as the abdomen.

Fasting is commonly incorporated, though evidence it’s required is limited.

Maintain consistent administration throughout the research cycle.

Research Considerations

5-Amino-1MQ’s NNMT-pathway mechanism is mechanistically distinct from GLP-1/GIP/glucagon-based compounds, making it a conceptually different tool for metabolic research rather than a substitute for appetite-focused compounds.

As with most compounds in this category, the promising preclinical signal should be clearly distinguished from established human outcomes.